Clinical Trial Update: Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

View source ↗

Summary

This completed clinical trial update examines the incidence of diabet ic ketoacidosis in participants with type 2 diabetes treated with SGLT2 inhibitors versus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Other antihyperglycemic agents (antihyperglycemic agent)
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED